# GABAPENTIN ENACARBIL
> **ANDA220420** · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA PRIVATE LIMITED · Approved 2026-03-20
## Drug
- **FDA Application Number:** ANDA220420
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GABAPENTIN ENACARBIL
- **Generic name:** Gabapentin Enacarbil
- **Active ingredients:** GABAPENTIN ENACARBIL
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ANNORA PHARMA PRIVATE LIMITED
- **First approval:** 2026-03-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220420)
---
*MORVS · CC0 1.0*